Article Text

other Versions

PDF
Activation of the epidermal growth factor signaling pathway by tissue plasminogen activator in pacreas cancer cells
  1. Mariano Hurtado (mhurtado{at}ir.vhebron.net)
  1. Institut de Recerca Hospital Vall d'Hebron, Spain
    1. Juan Jose Lozano
    1. Consejo Superior de Investigaciones Cient&iacficas, Centro de Biología Molecular Severo Ochoa, Spain
      1. Elisabeth Castellanos
      1. Institut de Recerca Hospital Vall d'Hebron, Spain
        1. Luis A Lopez-Fernández
        1. Centro Nacional de Biotecnología, Spain
          1. Keith Harshman
          1. Centro Nacional de Biotecnología, Spain
            1. Carlos Martinez-A.
            1. Centro Nacional de Biotecnología, Spain
              1. Angel R Ortiz
              1. Consejo Superior de Investigaciones Cient&iacficas, Centro de Biología Molecular Severo Ochoa, Spain
                1. Timothy M Thomson (titbmc{at}cid.csic.es)
                1. Consejo Superior de Invastigaciones Científicas, Institut de Biologia Molecular Barcelona, Spain
                  1. Rosanna Paciucci (rpaciucci{at}ir.vhebron.net)
                  1. Institut de Recerca Hospital Vall d'Hebron, Spain

                    Abstract

                    Background: Tissue plasminogen activator (tPA) is the major activator of plasminogen in plasma. This serine protease is overexpressed by exocrine pancreas tumor cells, where it promotes tumor cell proliferation, growth and invasion. Here we have explored the signaling pathways used by tPA to activate the proliferation of pancreatic cancer cells.

                    Methods: Comparative transcriptional profiling on cDNA micro arrays were used to analyze the pattern of gene expression of tPA with respect to known growth factors like epidermal growth factor (EGF) and platelet-derived growth factor (PDGF). Results were confirmed using different biochemical assays in which specific kinase inhibitors or RNA interference were used.

                    Results: The transcriptional profiling showed that tPA modulates the expression of a set of genes commonly regulated by EGF, but distinct from the major set of genes modulated by PDGF. This suggested that tPA and EGF share signaling pathways, a conclusion supported by further experimental evidence. First, we found that tPA induced a rapid and transient phosphorylation of the EGFR. Second, specific EGFR kinase inhibitors, but not PDGFR kinase inhibitors, abolished the tPA-induced phosphorylation of the ERK1/2 kinases and cell proliferation. The mitogenic activity of tPA was also inhibited by siRNA depletion of EGFR, thus confirming the involvement of this receptor and in tPA-triggered signaling. Third, we show that the signaling and mitogenic effects of tPA require its proteolytic activity, the activity of the metalloprotease-9 and active hb-EGF.

                    Conclusion: Our results suggest that tPA induces proliferation by triggering a proteolytic cascade that sequentially activates plasmin, MMP-9 and hb-EGF. These events are required to activate the EGFR signaling pathway and cell proliferation.

                    • EGF receptor
                    • microarrays
                    • pancreas cancer
                    • proliferation
                    • tissue plasminogen activator

                    Statistics from Altmetric.com

                    Request permissions

                    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.